1. Home
  2. TWN vs BBNX Comparison

TWN vs BBNX Comparison

Compare TWN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TWN

Taiwan Fund Inc. (The)

HOLD

Current Price

$85.80

Market Cap

550.8M

Sector

Finance

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$15.85

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWN
BBNX
Founded
N/A
2015
Country
United States
United States
Employees
N/A
423
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
550.8M
493.1M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
TWN
BBNX
Price
$85.80
$15.85
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$23.80
AVG Volume (30 Days)
41.6K
994.2K
Earning Date
01-01-0001
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$34.90
Revenue Next Year
N/A
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$45.31
$8.80
52 Week High
$105.09
$32.71

Technical Indicators

Market Signals
Indicator
TWN
BBNX
Relative Strength Index (RSI) 38.74 50.51
Support Level $53.13 $9.34
Resistance Level $102.77 $32.52
Average True Range (ATR) 3.16 1.17
MACD -0.73 -0.25
Stochastic Oscillator 24.51 18.16

Price Performance

Historical Comparison
TWN
BBNX

About TWN Taiwan Fund Inc. (The)

Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: